Sanofi Sues Sandoz To Protect Ambien Patent
Sanofi-Aventis filed suit Friday against Sandoz Inc., the generics subsidiary of Novartis AG, in an effort to keep Sandoz from marketing its own version of Sanofi's popular insomnia drug Ambien CR....To view the full article, register now.
Already a subscriber? Click here to view full article